The supply agreement is designed to support the evaluation of Immuneerings lead candidate, atebimetinib (IMM-1-104), a novel dual MEK inhibitor, in combination with olomorasib in a planned Phase II trial in patients with locally advanced or metastatic KRAS G12c-mutant non-small cell lung cancer (NSCLC) who have progressed on prior therapy
Drinking water slowly throughout the day rather than with meals, and eating meals 1-2 hours apart, allows your stomach to function without overwhelming the slowed-transit system
Why Folinic Acid Instead of 5-MTHF
Currently, this medicine is undergoing stage 3 clinical trials, which are expected to conclude in May 2026
In contrast, inflammatory stimuli diminish the expression of HDAC5 to regulate the generation of cytokines and chemokines through modulation of IRF1 in RA FLS (302)
Manufactured in a GMP-Certified Facility Produced under strict quality standards to ensure safety, purity, and potency